The role of brachytherapy in the definitive management of prostate cancer

J Crook - Cancer/Radiothérapie, 2011 - Elsevier
… traverse normal structures to reach the prostatic target. This article will review the expanding
indications for brachytherapy in prostate cancer, the techniques and the published results. …

Management of prostate cancer recurrence after definitive radiation therapy

C Boukaram, JM Hannoun-Levi - Cancer treatment reviews, 2010 - Elsevier
The management of prostate cancer (PC) recurrence after definitive radiation therapy (RT) …
Based on a Pubmed data search, this manuscript focused on the management of post-RT …

[HTML][HTML] Radiation therapy in the definitive management of oligometastatic prostate cancer: the Johns Hopkins experience

MP Deek, C Yu, R Phillips, DY Song, C Deville… - International Journal of …, 2019 - Elsevier
… treating oligometastatic prostate cancer with definitive intent … wide range of oligometastatic
prostate cancer subtypes, but with … wide range of patients with oligometastatic prostate cancer. …

Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification

ND Shore, JW Moul, KJ Pienta, J Czernin… - … Cancer and Prostatic …, 2024 - nature.com
… This narrative review examines the utility of risk stratification for the management of patients
with BCR in the context of clinical trial data, referencing the latest recommendations by …

An analysis of men with clinically localized prostate cancer who deferred definitive therapy

MI Patel, DT DeCONCINI, E Lopez-Corona… - The Journal of …, 2004 - auajournals.org
… We evaluated expectant management of prostate cancer with definitive treatment
deferred until evidence of cancer progression in men with low risk, localized cancers. …

Is prostate brachytherapy a dying art? Trends and variation in the definitive management of prostate cancer in Ontario, Canada

MT Corkum, G Morton, AV Louie, GS Bauman… - Radiotherapy and …, 2020 - Elsevier
… initial definitive management of prostate cancer in Ontario, Canada. We sought to identify
patient- and provider-level predictors of treatment utilization, with a particular focus on prostate

[HTML][HTML] Management algorithms for prostate-specific antigen progression in prostate cancer: Biochemical recurrence after definitive therapy and progression to non …

B Danielson, F Saad, A So, S Morgan… - Canadian Urological …, 2019 - ncbi.nlm.nih.gov
Management algorithm for prostate cancer patients with a biochemical recurrence after
radical local therapy. This algorithm does not address other aspects of care such as bone health …

The addition of chemotherapy in the definitive management of high risk prostate cancer

MJ Ferris, Y Liu, J Ao, J Zhong, M Abugideiri… - … Oncology: Seminars and …, 2018 - Elsevier
… to which CTX has been incorporated into definitive treatment of high-risk prostate cancer
thus far in the United States, we sought to utilize the National Cancer Data Base (NCDB) to …

National Comprehensive Cancer Network guidelines for the management of prostate cancer

D Scherr, PW Swindle, PT Scardino - Urology, 2003 - Elsevier
… After definitive therapy, patients should be monitored with PSA determinations, … prostate
cancer is complex. Optimal treatment is risk-adapted to the specific characteristics of the cancer

Systematic review of time to definitive treatment for intermediate risk and high risk prostate cancer: Are delays associated with worse outcomes?

DD Nguyen, L Haeuser, M Paciotti, C Reitblat… - The Journal of …, 2021 - auajournals.org
… in PCa treatment since this shift in its management, we sought to determine if treatment … the
evidence in a definitive manner to inform the prioritization of backlogged cancer care. As such…